Showcasing the best countries to invest in this year London, Sept. 14, 2023 (GLOBE NEWSWIRE) — Today, the seventh edition of the CBI Index launched, providing captivating insights into the world’s top investment migration programmes in 2023. From inception, the CBI Index, published in partnership with the Financial Times’ Private Wealth Magazine has been comprehensively […]
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ The world is at ‘Halftime’ when it comes to achieving 2030 Sustainable Development Goals – but only 15% are on track to be met Richard Curtis releases new version of Pacino’s famous locker room speech to mark this halftime point LONDON, […]
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ O mundo está no período de intervalo para alcançar os Objetivos de Desenvolvimento Sustentável até 2030 – mas apenas 15% deles estão a caminho de ser cumpridos Richard Curtis lança nova versão da famosa cena do balneário de Al Pacino para […]
Al Pacino still from ‘Inches (with Al Pacino)| The Global Goals | Halftime 2023’ Le monde est à la « mi-temps » de son échéance pour la réalisation des Objectifs de Développement Durable pour 2030, mais seuls 15 % de ces objectifs sont en voie d’être atteints Richard Curtis sort une nouvelle version du célèbre discours des vestiaires […]
AI-Media Exhibits at IBC 2023 BROOKLYN, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — AI-Media, the leader in technology-driven live captioning & subtitling, transcription, and translation solutions, is excited to announce its presence at the IBC Show 2023, scheduled to take place from 15th – 18th September in Amsterdam, NE. The event promises to be a […]
O fornecimento de um fármaco fabricado segundo as normas de BPFa apoia o primeiro estudo clínico em seres humanos do novo RNA autorreplicante (srRNA) RBI-4000 ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje que sua parceira, Replicate Bioscience, recebeu autorização IND […]
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating RNA (srRNA) ALBANY, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that its partner, Replicate Bioscience, has received IND clearance from the FDA and has dosed the first participant with […]
L’entreprise apporte une substance médicamenteuse fabriquée selon les BPFa afin de permettre la première étude clinique chez un être humain du nouvel ARN auto-répliquant (ARNar) RBI-4000 ALBANY, ÉTAT DE NEW YORK, 13 sept. 2023 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, développement et fabrication en sous-traitance de premier plan, a annoncé aujourd’hui que son […]